Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial

Summary Background Intensive care units (ICUs) are high-risk areas for transmission of antimicrobial-resistant bacteria, but no controlled study has tested the effect of rapid screening and isolation of carriers on transmission in settings with best-standard precautions. We assessed interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in European ICUs. Methods We did this study in three phases at 13 ICUs. After a 6 month baseline period (phase 1), we did an interrupted time series study of universal chlorhexidine body-washing combined with hand hygiene improvement for 6 months (phase 2), followed by a 12–15 month cluster randomised trial (phase 3). ICUs were randomly assigned by computer generated randomisation schedule to either conventional screening (chromogenic screening for meticillin-resistant Staphylococcus aureus [MRSA] and vancomycin-resistant enterococci [VRE]) or rapid screening (PCR testing for MRSA and VRE and chromogenic screening for highly resistant Enterobacteriaceae [HRE]); with contact precautions for identified carriers. The primary outcome was acquisition of resistant bacteria per 100 patient-days at risk, for which we calculated step changes and changes in trends after the introduction of each intervention. We assessed acquisition by microbiological surveillance and analysed it with a multilevel Poisson segmented regression model. We compared screening groups with a likelihood ratio test that combined step changes and changes to trend. This study is registered with ClinicalTrials.gov, number NCT00976638. Findings Seven ICUs were assigned to rapid screening and six to conventional screening. Mean hand hygiene compliance improved from 52% in phase 1 to 69% in phase 2, and 77% in phase 3. Median proportions of patients receiving chlorhexidine body-washing increased from 0% to 100% at the start of phase 2. For trends in acquisition of antimicrobial-resistant bacteria, weekly incidence rate ratio (IRR) was 0·976 (0·954–0·999) for phase 2 and 1·015 (0·998–1·032) for phase 3. For step changes, weekly IRR was 0·955 (0·676–1·348) for phase 2 and 0·634 (0·349–1·153) for phase 3. The decrease in trend in phase 2 was largely caused by changes in acquisition of MRSA (weekly IRR 0·925, 95% CI 0·890–0·962). Acquisition was lower in the conventional screening group than in the rapid screening group, but did not differ significantly (p=0·06). Interpretation Improved hand hygiene plus unit-wide chlorhexidine body-washing reduced acquisition of antimicrobial-resistant bacteria, particularly MRSA. In the context of a sustained high level of compliance to hand hygiene and chlorhexidine bathings, screening and isolation of carriers do not reduce acquisition rates of multidrug-resistant bacteria, whether or not screening is done with rapid testing or conventional testing. Funding European Commission.

[1]  J. A. Kaan,et al.  Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. , 2010, American journal of respiratory and critical care medicine.

[2]  S. Weber,et al.  Screening for Methicillin-Resistant Staphylococcus aureus , 2009, Infection Control & Hospital Epidemiology.

[3]  B. Cooper,et al.  Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation , 2011, BMJ : British Medical Journal.

[4]  M. Bonten,et al.  Staphylococcus aureus Infections Revisited , 2012 .

[5]  Victoria J. Fraser,et al.  The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial* , 2009, Critical care medicine.

[6]  Matthew Samore,et al.  Intervention to reduce transmission of resistant bacteria in intensive care. , 2011, The New England journal of medicine.

[7]  S. El-Kamary,et al.  Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  B S Cooper,et al.  Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature , 2004, BMJ : British Medical Journal.

[9]  Tanya Gurieva,et al.  Cost and Effects of Different Admission Screening Strategies to Control the Spread of Methicillin-resistant Staphylococcus aureus , 2013, PLoS Comput. Biol..

[10]  Ben S Cooper,et al.  Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  H. Goossens,et al.  Current Trends in Culture-Based and Molecular Detection of Extended-Spectrum-β-Lactamase-Harboring and Carbapenem-Resistant Enterobacteriaceae , 2012, Journal of Clinical Microbiology.

[12]  J. O’Horo,et al.  The Efficacy of Daily Bathing with Chlorhexidine for Reducing Healthcare-Associated Bloodstream Infections: A Meta-analysis , 2012, Infection Control & Hospital Epidemiology.

[13]  Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  E. Wong,et al.  Effect of daily chlorhexidine bathing on hospital-acquired infection. , 2013, The New England journal of medicine.

[15]  F. Schmitz,et al.  Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. , 2001, The Journal of antimicrobial chemotherapy.

[16]  G. MacLennan,et al.  Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit. , 2007, International journal of antimicrobial agents.

[17]  R A Weinstein,et al.  Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. , 1996, JAMA.

[18]  Herman Goossens,et al.  Current Trends in Rapid Diagnostics for Methicillin-Resistant Staphylococcus aureus and Glycopeptide-Resistant Enterococcus Species , 2008, Journal of Clinical Microbiology.

[19]  Jonathan Aldridge,et al.  Isolation of Patients in Single Rooms or Cohorts to Reduce Spread of MRSA in Intensive Care Units: Prospective Two Centre Study , 2005 .

[20]  A. Cheng,et al.  Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. , 2012, The Journal of hospital infection.

[21]  H. Goossens,et al.  Evaluation of Chromogenic Media for Detection of Methicillin-Resistant Staphylococcus aureus , 2010, Journal of Clinical Microbiology.

[22]  Elsa Afonso,et al.  The value of chlorhexidine gluconate wipes and prepacked washcloths to prevent the spread of pathogens--a systematic review. , 2013, Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.

[23]  Richard Platt,et al.  Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Geert Molenberghs,et al.  Evaluation of Molecular Assays for Rapid Detection of Methicillin-Resistant Staphylococcus aureus , 2010, Journal of Clinical Microbiology.

[25]  C. Tinelli,et al.  Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. , 2007, The Journal of hospital infection.

[26]  M. Bonten,et al.  Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review , 2012, Intensive Care Medicine.

[27]  R. Platt,et al.  Targeted versus universal decolonization to prevent ICU infection. , 2013, The New England journal of medicine.

[28]  J. A. Kaan,et al.  Decontamination of the digestive tract and oropharynx in ICU patients. , 2009, The New England journal of medicine.

[29]  M. Bonten,et al.  Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units. , 2012, The Journal of antimicrobial chemotherapy.

[30]  Craig R Ramsay,et al.  INTERRUPTED TIME SERIES DESIGNS IN HEALTH TECHNOLOGY ASSESSMENT: LESSONS FROM TWO SYSTEMATIC REVIEWS OF BEHAVIOR CHANGE STRATEGIES , 2003, International Journal of Technology Assessment in Health Care.

[31]  B. Branger,et al.  Randomized Comparison of 2 Protocols to Prevent Acquisition of Methicillin-Resistant Staphylococcus aureus: Results of a 2-Center Study Involving 500 Patients , 2011, Infection Control & Hospital Epidemiology.

[32]  G. Wormser,et al.  Infection-Control Measures Reduce Transmission of Vancomycin-Resistant Enterococci in an Endemic Setting , 1999, Annals of Internal Medicine.